Valentina Mazzotta

3.4k total citations · 1 hit paper
65 papers, 921 citations indexed

About

Valentina Mazzotta is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Valentina Mazzotta has authored 65 papers receiving a total of 921 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 23 papers in Virology and 20 papers in Epidemiology. Recurrent topics in Valentina Mazzotta's work include Poxvirus research and outbreaks (15 papers), Herpesvirus Infections and Treatments (14 papers) and SARS-CoV-2 and COVID-19 Research (12 papers). Valentina Mazzotta is often cited by papers focused on Poxvirus research and outbreaks (15 papers), Herpesvirus Infections and Treatments (14 papers) and SARS-CoV-2 and COVID-19 Research (12 papers). Valentina Mazzotta collaborates with scholars based in Italy, United Kingdom and United States. Valentina Mazzotta's co-authors include Massimo Fantoni, Enrico Maria Trecarichi, Eugenia Di Meco, Andrea Antinori, Enrico Pola, Enrico Girardi, Francesco Vaia, Luigi Aurelio Nasto, Stefania Cicalini and Emanuele Nicastri and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and International Journal of Molecular Sciences.

In The Last Decade

Valentina Mazzotta

45 papers receiving 895 citations

Hit Papers

Epidemiological, clinical and virological characteristics... 2022 2026 2023 2024 2022 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Valentina Mazzotta Italy 13 458 390 356 291 182 65 921
Anna Paola Massetti Italy 16 216 0.5× 296 0.8× 71 0.2× 188 0.6× 334 1.8× 46 841
Estrella Caballero Spain 15 295 0.6× 136 0.3× 65 0.2× 46 0.2× 320 1.8× 38 775
C L Ingham Clark United Kingdom 11 137 0.3× 326 0.8× 135 0.4× 86 0.3× 64 0.4× 36 702
Huub C. Gelderblom United States 14 101 0.2× 193 0.5× 64 0.2× 60 0.2× 155 0.9× 27 517
Massimo Cernuschi Italy 14 146 0.3× 223 0.6× 34 0.1× 138 0.5× 235 1.3× 45 551
Alexander Nikas United States 8 109 0.2× 720 1.8× 99 0.3× 43 0.1× 160 0.9× 9 1.0k
Isabella Bon Italy 16 388 0.8× 143 0.4× 87 0.2× 43 0.1× 480 2.6× 74 770
Christopher P. Conlon United Kingdom 10 760 1.7× 409 1.0× 135 0.4× 38 0.1× 303 1.7× 13 1.4k
Barbara Kalsdorf Germany 16 67 0.1× 848 2.2× 94 0.3× 336 1.2× 931 5.1× 46 1.3k
Dennis Causey United States 11 243 0.5× 744 1.9× 61 0.2× 23 0.1× 251 1.4× 14 1.0k

Countries citing papers authored by Valentina Mazzotta

Since Specialization
Citations

This map shows the geographic impact of Valentina Mazzotta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valentina Mazzotta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valentina Mazzotta more than expected).

Fields of papers citing papers by Valentina Mazzotta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valentina Mazzotta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valentina Mazzotta. The network helps show where Valentina Mazzotta may publish in the future.

Co-authorship network of co-authors of Valentina Mazzotta

This figure shows the co-authorship network connecting the top 25 collaborators of Valentina Mazzotta. A scholar is included among the top collaborators of Valentina Mazzotta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valentina Mazzotta. Valentina Mazzotta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vergori, Alessandra, Giulia Matusali, Alessandro Cozzi Lepri, et al.. (2025). Supporting equitable booster strategies: one-year real-world immunogenicity data in people with HIV (PWH) receiving different variant-adapted COVID-19 vaccines. International Journal of Infectious Diseases. 163. 108189–108189.
2.
Giacomelli, Andrea, Cristina Mussini, Stephen R. Cole, et al.. (2025). Effectiveness of dolutegravir-based vs boosted darunavir-based first-line 3-drug regimens in people with HIV with advanced disease: A trial emulation. International Journal of Infectious Diseases. 155. 107883–107883.
3.
Mondi, Annalisa, Alessandro Cozzi‐Lepri, Valentina Mazzotta, et al.. (2025). Burden of advanced HIV disease among antiretroviral therapy-experienced persons with HIV in Italy over the past 20 years. International Journal of Infectious Diseases. 159. 108016–108016.
4.
Mazzotta, Valentina, Silvia Nozza, Simone Lanini, et al.. (2024). Clinical and laboratory predictors of mpox severity and duration: an Italian multicentre cohort study (mpox-Icona). EBioMedicine. 107. 105289–105289. 8 indexed citations
5.
Mastrorosa, Ilaria, Alessandro Cozzi Lepri, Cosmo Del Borgo, et al.. (2024). Incidence and predictors of clinical failure after early treatment for mild‐to‐moderate COVID‐19 in high‐risk individuals: A multicentric cohort study. Journal of Internal Medicine. 297(3). 328–334.
6.
Sberna, Giuseppe, Gabriella Rozera, Claudia Minosse, et al.. (2024). Role of Direct Sexual Contact in Human Transmission of Monkeypox Virus, Italy. Emerging infectious diseases. 30(9). 1829–1833. 4 indexed citations
7.
Bordi, Licia, Federica Frasca, Valentina Mazzotta, et al.. (2024). MPXV infection impairs IFN response but is partially sensitive to IFN-γ antiviral effect. Medical Microbiology and Immunology. 213(1). 25–25. 5 indexed citations
8.
Vergori, Alessandra, Patrizia Lorenzini, Ilaria Mastrorosa, et al.. (2024). Impact of switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate to bictegravir/emtricitabine/tenofovir alafenamide on psychiatric symptoms and neurocognition. AIDS. 39(3). 270–275. 3 indexed citations
9.
Valli, Maria Beatrice, Antonella Vulcano, Martina Rueca, et al.. (2024). Concomitant Syndromic Diagnosis of Mpox and Other Vesicular Viruses in Patients with Skin and Genital Lesions. Pathogens. 13(3). 207–207. 2 indexed citations
10.
Vita, Serena, Emanuela Giombini, Patrizia De Marco, et al.. (2024). Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era. Mediterranean Journal of Hematology and Infectious Diseases. 16(1). e2024043–e2024043.
11.
Matusali, Giulia, Alessandra Vergori, Eleonora Cimini, et al.. (2024). Poor durability of the neutralizing response against XBB sublineages after a bivalent mRNA COVID‐19 booster dose in persons with HIV. Journal of Medical Virology. 96(4). e29598–e29598. 1 indexed citations
12.
Vergori, Alessandra, Alessandro Cozzi‐Lepri, Alessandro Tavelli, et al.. (2024). SARS-CoV-2 mRNA vaccination and short-term changes in viral load and CD4/CD8 T-cell counts in people living with HIV. International Journal of Infectious Diseases. 144. 107065–107065.
13.
Gruber, Cesare Ernesto Maria, Emanuela Giombini, Valentina Mazzotta, et al.. (2024). Molnupiravir increases SARS‐CoV‐2 genome diversity and complexity: A case‐control cohort study. Journal of Medical Virology. 96(5). e29642–e29642. 2 indexed citations
14.
Gagliardini, Roberta, Alessandro Tavelli, Giuseppe Lapadula, et al.. (2024). OC-10 Effectiveness of long-acting art with cabotegravir/rilpivirine in the icona cohort. A8–A9.
15.
Colavita, Francesca, Giulia Matusali, Valentina Mazzotta, et al.. (2023). Profiling the acute phase antibody response against mpox virus in patients infected during the 2022 outbreak. Journal of Medical Virology. 95(6). e28851–e28851. 12 indexed citations
16.
Rueca, Martina, Valentina Mazzotta, Giulia Gramigna, et al.. (2023). Temporal intra‐host variability of mpox virus genomes in multiple body tissues. Journal of Medical Virology. 95(5). e28791–e28791. 10 indexed citations
17.
Giacomelli, Andrea, Roberta Gagliardini, Alessandro Tavelli, et al.. (2023). Risk of COVID-19 in-hospital mortality in people living with HIV compared to general population according to age and CD4 strata: data from the ICONA network. International Journal of Infectious Diseases. 136. 127–135. 10 indexed citations
18.
Bordi, Licia, Giuseppe Sberna, Eleonora Lalle, et al.. (2023). Comparison of SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples from Patients Infected with Omicron Variant. International Journal of Molecular Sciences. 24(5). 4847–4847. 4 indexed citations
19.
Gruber, Cesare Ernesto Maria, Martina Rueca, Valentina Mazzotta, et al.. (2023). Treatment-Emergent Cilgavimab Resistance Was Uncommon in Vaccinated Omicron BA.4/5 Outpatients. Biomolecules. 13(10). 1538–1538. 1 indexed citations
20.
Antinori, Andrea, Valentina Mazzotta, Serena Vita, et al.. (2022). Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022. Eurosurveillance. 27(22). 360 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026